| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/23/2011 | CN101664449B Separation method of rhubarb-combined anthraquinone and rhubarb tannin |
| 03/23/2011 | CN101543481B Double-layer breviscapine sustained-release tablet and preparation method thereof |
| 03/23/2011 | CN101439047B Technological process for improving stable FVII yield of human prothrombin complexes |
| 03/23/2011 | CN101428115B Medicinal liquor for reinforcing body fluid and nourishing the blood for women |
| 03/23/2011 | CN101417064B Traditional Chinese medicine combination for treating gynecology blood disease and preparation method thereof |
| 03/23/2011 | CN101372512B Anticoagulated blood polypeptides and uses thereof |
| 03/23/2011 | CN101313873B Biology polypeptide medicament blood vessel bracket and preparation method thereof |
| 03/23/2011 | CN101274000B Medicine use of herb aralia elata seem |
| 03/23/2011 | CN101199753B Oral administration Chinese medicine for treating dryness-heat cough hemoptysis |
| 03/23/2011 | CN101175751B Crystal of indole derivative having piperidine ring and process for production thereof |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | CA2614979C Piretanide polymorph, process for its preparation and its use |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/22/2011 | CA2280949C Dextran derivatives, preparation method and applications as medicine with specific biological action |
| 03/17/2011 | WO2011029832A1 Novel thiazol and oxazol hepcidine antagonists |
| 03/17/2011 | WO2010118435A3 Par-1 activation by metalloproteinase-1 (mmp-1) |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065756 Methods and compositions for treatment of obesity-related diseases |
| 03/17/2011 | US20110065735 Substituted quinazolines |
| 03/17/2011 | US20110065717 Sulfoximine derivatives as factor xa inhibitors |
| 03/17/2011 | US20110065714 Substituted quinazolines |
| 03/17/2011 | US20110065682 Heterocyclic compounds as factor ixa inhibitors |
| 03/17/2011 | US20110065679 Substituted Porphyrins |
| 03/17/2011 | US20110064811 Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/17/2011 | US20110064786 Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells |
| 03/17/2011 | US20110064785 Nanostructure-Enhanced Platelet Binding and Hemostatic Structures |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064714 Factor viia-polysialic acid conjugate having prolonged in vivo half-life |
| 03/17/2011 | US20110064704 Ship-deficiency to increase megakaryocyte and platelet production |
| 03/17/2011 | US20110064691 Method to enhance hematopoiesis |
| 03/17/2011 | US20110064663 Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295435A1 Substituted porphyrins and their therapeutic use |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294087A1 Anti-hepcidin antibodies and methods of use |
| 03/16/2011 | EP2294066A1 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 03/16/2011 | EP2132194B1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 03/16/2011 | EP1495018B3 Tricyclic thrombin receptor antagonists |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1420010B1 Amphoteric lipid compound and use thereof |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | EP1248796B1 Process for the purification of antithrombin-iii |
| 03/16/2011 | CN1939324B Medical usage of periplocin A and E |
| 03/16/2011 | CN101985042A Medicinal composition for resisting thrombus |
| 03/16/2011 | CN101985039A Medicinal composition for resisting thrombus |
| 03/16/2011 | CN101985038A Medicinal composition for resisting thrombus |
| 03/16/2011 | CN101985033A Compound traditional Chinese medicine for treating stubborn diseases |
| 03/16/2011 | CN101985000A Thrombus Chinese patent oral medicine |
| 03/16/2011 | CN101984983A Lamiophlomis rotata extract, medicine composition containing same and quality control method thereof |
| 03/16/2011 | CN101984971A Drug composition containing clopidogrel and nicotinic acid compounds |
| 03/16/2011 | CN101984969A Drug composition containing clopidogrel and fibrate compounds |
| 03/16/2011 | CN101810706B Preparation method of garden burnet solid preparation with low dose |
| 03/16/2011 | CN101804103B Drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor and preparation method thereof |
| 03/16/2011 | CN101601850B Lactagogue and health care traditional Chinese medicine for lying-in women |
| 03/16/2011 | CN101530436B Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 03/16/2011 | CN101475651B Preparation of Gracilaria gigas Harvey polysaccharides |
| 03/16/2011 | CN101332182B Preparation method of emulsion containing alprostadil for intravenous transfusion |
| 03/16/2011 | CN101306097B Zengkangning tablets quality control method |
| 03/16/2011 | CN101264150B Chinese medicinal composition containing radix astragali and preparation thereof |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906491 Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs) |
| 03/15/2011 | US7906139 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2433806C Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/15/2011 | CA2404196C Medical emulsion for lubrication and delivery of drugs |
| 03/15/2011 | CA2202875C Process for purifying factor viii |
| 03/10/2011 | WO2011029102A2 Cd117+cells and uses thereof |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011028234A1 Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid |
| 03/10/2011 | WO2011028098A1 Product and method for treating thrombocytopenia |
| 03/10/2011 | WO2011027175A1 Antithrombotic compounds |
| 03/10/2011 | WO2011026959A1 Novel ethane diamine hepcidin antagonists |
| 03/10/2011 | WO2011026835A1 Novel pyrimidine and triazine hepcidine antagonists |
| 03/10/2011 | WO2011026259A1 Pharmaceutical compositon for anti-thrombotic diseases, its preparation method and use |
| 03/10/2011 | WO2010087986A3 Resuscitation fluid |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060040 Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110059981 New Pyridine Analogues V |
| 03/10/2011 | US20110059958 Morpholinone compounds as factor ixa inhibitors |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059895 Modulation of factor 9 expression |
| 03/10/2011 | US20110059894 Factor VII Polypeptides for Preventing Formation of Inhibitors in Subjects with Haemophilia |
| 03/10/2011 | US20110059893 Compounds for the treatment of proliferative disorders |
| 03/10/2011 | US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |